Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Small Vessel Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05671770
What this trial is testing

Study Based on Electronic Health RecOrds to Identify Patients at High-risk of Fabry DiseasE (HOPE Fabry)

Who this might be right for
Fabry Disease
Sanofi 15
Not applicableUnknownNCT06319495
What this trial is testing

Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease

Who this might be right for
Cerebral Small Vessel Diseases
Copka Sonpashan 80
Not applicableUnknownNCT04569643
What this trial is testing

Periodic Limb Movement Syndrome in Patients With Cerebral Small Vessel Disease.

Who this might be right for
Periodic Limb Movement DisorderCerebral Small Vessel DiseasesCognitive Dysfunction
I.M. Sechenov First Moscow State Medical University 76
Not applicableEnded earlyNCT00149318
What this trial is testing

Enzyme Replacement Therapy in Fabry Disease

Who this might be right for
Fabry Disease
Mario Negri Institute for Pharmacological Research 2
Large-scale testing (Phase 3)Study completedNCT03614234
What this trial is testing

Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients

Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A. 29
Very early researchLooking for participantsNCT06207552
What this trial is testing

Evaluation of the Safety, Tolerability and Efficacy of a Gene Therapy Drug for the Treatment of Pediatric Fabry Disease

Who this might be right for
Fabry Disease
Children's Hospital of Fudan University 6
Testing effectiveness (Phase 2)Study completedNCT00196716
What this trial is testing

The Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 21
Not applicableLooking for participantsNCT03004326
What this trial is testing

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Who this might be right for
Cryoglobulinemic Vasculitis (CV)Drug-induced VasculitisEosinophilic Granulomatosis With Polyangiitis (EGPA)+7 more
Peter Merkel 50
Not applicableUnknownNCT01442350
What this trial is testing

Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of Biomarkers

Who this might be right for
Fabry Disease, Cardiac VariantRight Ventricular Hypertrophy
Francisco Marín Ortuño 120
Not applicableStudy completedNCT02798458
What this trial is testing

Evaluation of the Gastrointestinal Manifestation of Fabry's Disease

Who this might be right for
Fabry's Disease
Massachusetts General Hospital 48
Not applicableLooking for participantsNCT06663358
What this trial is testing

A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients

Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A. 100
Not applicableStudy completedNCT01745185
What this trial is testing

Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta

Who this might be right for
Fabry Disease
O & O Alpan LLC 30
Not applicableLooking for participantsNCT06607471
What this trial is testing

Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.

Who this might be right for
Non-ischemic CardiomyopathyDilated Cardiomyopathy (DCM)Hypertrophic Cardiomyopathy (HCM)+12 more
Scientific Institute San Raffaele 15,000
Not applicableLooking for participantsNCT04310098
What this trial is testing

CADASIL Registry Study

Who this might be right for
Cadasil
Bin Cai 1,000
Not applicableNo Longer AvailableNCT01370447
What this trial is testing

EPI-743 for Mitochondrial Respiratory Chain Diseases

Who this might be right for
Mitochondrial Diseases
PTC Therapeutics
Not applicableLooking for participantsNCT06579664
What this trial is testing

Intermittent Theta Burst Stimulation on Cognitive Impairment of Cerebral Small Vessel Disease

Who this might be right for
Cerebral Small Vessel DiseasesCognitive Impairment
Beijing Tiantan Hospital 58
Not applicableStudy completedNCT00446862
What this trial is testing

The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study

Who this might be right for
Fabry DiseaseProteinuria
University of Alabama at Birmingham 36
Not applicableWithdrawnNCT00900120
What this trial is testing

Collecting and Storing Blood Samples From Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Study completedNCT01730482
What this trial is testing

Assess the Absorption, Metabolism and Excretion of Migalastat Hydrochloride (AT1001-014)

Who this might be right for
Fabry Disease
Amicus Therapeutics 6
Testing effectiveness (Phase 2)UnknownNCT04109963
What this trial is testing

Trial of Remote Ischemic Pre-conditioning in Vascular Cognitive Impairment

Who this might be right for
Vascular DementiaCerebral Small Vessel DiseasesCerebral Small Vessel Ischaemic Disease+1 more
University of Calgary 24
Next Page